Data / Medical devices / Switzerland / Roche Diagnostics International Ltd.
Roche Diagnostics International Ltd.: FDA-registered device maker in ROTKREUZ Zug, Switzerland, 24 510(k) clearances and 6 PMA approvals
Roche Diagnostics International Ltd. is registered with the FDA (registration 3003795116) in ROTKREUZ Zug, Switzerland. It lists 158 device types. The FDA files 24 510(k) clearances and 6 PMA approvals under its listings, the newest dated January 16, 2025. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3003795116
- Address
- Forrenstrasse 2, ROTKREUZ Zug, Switzerland, CH-6343
- Owner or operator
- Roche Diagnostics Operations Inc. (9039767)
- Roles
- Contract manufacturer, Exporter to the US, Manufacturer, Repackager or relabeler, Specification developer
- First device listed
- March 6, 2001
- Registered through
- 2027
- Brand names listed
- 579-2-RSA Dynamic Interface v1.1, 713-2-cobase 8100 v1.5, 770-1-CCM-AOB v1.1, A1CD, cobas c 503, AMPLILINK Software Version 3.4, AST 1100Tests cobas c 701, AST/GOT 400T cobas c 111, ASTPM, 740Tests, cobas c 701 and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| January 16, 2025 | K240197 | cobas® liat CT/NG/MG nucleic acid test | QEP | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| July 27, 2023 | K223591 | cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System | QOF | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| September 16, 2022 | K220134 | cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSH | CFR | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| September 2, 2020 | K202215 | cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit | QMI | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| July 30, 2020 | DEN200015 | cobas EBV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit | QLX | Unknown | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| March 21, 2018 | K173887 | cobas CT/NG for use on cobas 6800/8800 systems | LSL | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| September 12, 2017 | K171770 | cobas Cdiff Nucleic acid test for use on the cobas Liat System | OZN | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| January 23, 2017 | K162606 | Elecsys TSH assay, cobas e 801 Immunoassay analyzer | JLW | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 25, 2016 | K153544 | cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System | OCC | Substantially Equivalent | Iquum, Inc. | accessdata.fda.gov |
| June 1, 2015 | K150617 | cobas HSV 1 and 2 Test | OQO | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| May 20, 2015 | K142422 | cobas Cdiff Test | OZN | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| December 17, 2014 | K142721 | cobas MRSA/SA Test | NQX | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| November 4, 2014 | K141338 | LIAT STREP A ASSAY | PGX | Substantially Equivalent | Iquum, Inc. | accessdata.fda.gov |
| December 2, 2013 | K132270 | COBAS CT/NG V2.0 TEST | LSL | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| May 14, 2012 | K111188 | COBAS B 123 POC SYSTEM, COBAS B 123 AUTOQC PACK TRI-LEVEL, COBAS B 123 AUTOCVC PACK, ROCHE COMBITROL PLUS B | CHL | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| August 4, 2011 | K111387 | LIAT (TM) INFLUENZA A / B ASSAY, LIAT (TM) ANALYZER | OCC | Substantially Equivalent | Iquum, Inc. | accessdata.fda.gov |
| September 9, 2010 | K100853 | COBAS 8000 MODULAR SERIES ANALYZER | DCF | Substantially Equivalent | Roche Diagnostics Corp. | accessdata.fda.gov |
| April 2, 2010 | K093555 | COBAS U411 TEST SYSTEM | KQO | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 30, 2007 | K071211 | COBAS C 111 ANALYZER | CIT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 17, 2003 | K032311 | ROCHE DIAGNOSTICS OMNI S ANALYZER | CEM | Substantially Equivalent | Roche Diagnostics Corp. | accessdata.fda.gov |
| August 28, 2003 | K032453 | ROCHE COMBITROL AND AUTOTROL PLUS B MULTI ANALYTE CONTROL | JJY | Substantially Equivalent | Bionostics, Inc. | accessdata.fda.gov |
| February 1, 2002 | K012966 | ROCHE COBAS TAQMAN ANALYZER | JJF | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| June 12, 1996 | K961458 | AVL 9180 ELECTROLYTE ANALYZER | JFP | Substantially Equivalent | Avl Scientific Corp. | accessdata.fda.gov |
| September 8, 1995 | K951595 | ROCHE COBAS INTEGRA ANALYZER, REAGENT CASSETTES | CGX | Substantially Equivalent | Roche Diagnostic Systems, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| June 18, 2020 | P200014 | cobas® EZH2 Mutation Test | OWD | 10 | March 17, 2026 | accessdata.fda.gov |
| June 1, 2017 | P160041 | COBAS CMV | PAB | 46 | October 10, 2024 | accessdata.fda.gov |
| October 14, 2015 | P150015 | COBAS HCV TEST | MZP | 42 | June 2, 2021 | accessdata.fda.gov |
| October 14, 2015 | P150014 | COBAS HBV TEST | MKT | 57 | October 17, 2025 | accessdata.fda.gov |
| April 19, 2011 | P100020 | COBAS HPV TEST | MAQ | 64 | March 17, 2026 | accessdata.fda.gov |
| July 3, 2001 | P000012 | COBAS AMPLICOR (TM) HEPATITIS C VIRUS (HCV) TEST, V2.0 | MZP | 51 | August 4, 2016 | accessdata.fda.gov |
Compare with other makers
- All makers of Respiratory Virus Panel Nucleic Acid Assay System
- All makers of Real Time Nucleic Acid Amplification System
- All makers of Influenza A And Influenza B Multiplex Nucleic Acid Assay
- All makers of Electrode, Ion Specific, Sodium
- All makers of Analyzer, Chemistry (Photometric, Discrete), For Clinical Use
- All makers of Radioimmunoassay, Thyroid-Stimulating Hormone
Updated March 17, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.